Characteristics and management of patients with idiopathic pulmonary fibrosis treated with pirfenidone capsule or tablet formulation

V. Cottin (Lyon, France), S. Guéguen (Paris, France), S. Jouneau (Rennes, France), H. Nunes (Avicenne, France), B. Crestani (Paris, France), P. Bonniaud (Dijon, France), L. Wemeau (Lilles, France), D. Israel-Biet (Paris, France), M. Chevereau (Paris, France), I. Dufaure-Garé (Paris, France), S. Amselem (Paris, France), A. Clément (Paris, France)

Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Session: Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Session type: E-poster session
Number: 1853
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Cottin (Lyon, France), S. Guéguen (Paris, France), S. Jouneau (Rennes, France), H. Nunes (Avicenne, France), B. Crestani (Paris, France), P. Bonniaud (Dijon, France), L. Wemeau (Lilles, France), D. Israel-Biet (Paris, France), M. Chevereau (Paris, France), I. Dufaure-Garé (Paris, France), S. Amselem (Paris, France), A. Clément (Paris, France). Characteristics and management of patients with idiopathic pulmonary fibrosis treated with pirfenidone capsule or tablet formulation. 1853

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: